№ files_lp_4_process_3_134394
File format: docx
Character count: 26041
File size: 53 KB
Year:
2026
Country:
Japan
Topic:
Cancer pain management
Document type:
Research article
Institution:
Juntendo University Graduate School of Medicine; National Cancer Center Hospital East; Saga-ken Medical Centre Koseikan; St. Marianna University School of Medicine; Tohoku University Graduate School of Medicine; Seirei Mikatahara General Hospital
Authors:
Yuko Uehara, Yoshihisa Matsumoto, Toshifumi Kosugi, Miyuki Sone, Naoki Nakamura, Akio Mizushima, Mitsunori Miyashita, Tatsuya Morita, Takuhiro Yamaguchi, Eriko Satomi
Target audience:
Palliative care physicians, interventional radiologists, oncologists, home hospice physicians
Study type:
Nationwide cross-sectional survey
Methods:
Self-administered questionnaire on four interventional procedures for cancer pain; descriptive and multivariate statistical analysis
Key procedures studied:
Celiac plexus neurolysis (CPN), phenol saddle block, epidural analgesia, intrathecal analgesia
Data collection period:
Past 3 years
Response rate:
545/1,112 PSs, 554/1,087 IVR specialists, 144/308 HHPs, 399/800 oncologists
Corresponding author:
Yoshihisa Matsumoto, National Cancer Center Hospital East, Kashiwa, Japan
Context:
Nationwide survey research article documenting the utilization, frequency, and factors influencing interventional procedures for refractory cancer pain among specialists and their familiarity among oncologists and home hospice physicians.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2018
Region / city:
Vale of York, Scarborough and Ryedale
Theme:
Varicose Veins Management
Document type:
Commissioning Policy
Organization:
NHS Vale of York and Scarborough and Ryedale CCGs
Author:
Not specified
Target audience:
Healthcare professionals, Primary care clinicians, Vascular surgeons
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
2018
Document type:
Guidance document
Subject:
Informed consent in interventional clinical trials
Population:
Healthy adult participants
Scope:
Interventional clinical trials with trial medicine
Jurisdiction:
Belgium
Organizations mentioned:
CT College; Healixia; Ethics Committees; Belgian Data Protection Authority
Language versions:
English; French; Dutch
Intended users:
Clinical trial sponsors
Regulatory context:
Ethics Committee submission requirements
Version:
1.0
Year:
2024
Region / City:
Ireland
Topic:
Clinical Trials, Legal Agreements, Healthcare
Document Type:
Explanatory Note
Organization:
HSE, IPHA
Target Audience:
Contract Research Organizations, Hospitals, Pharmaceutical Companies
Effective Date:
20.05.24
Related Date:
20.05.24
Approval Date:
20.05.24
Year:
2021
Region / City:
Brussels
Topic:
Clinical Research Ethics
Document Type:
Submission Form
Institution:
Saint-Luc University Clinics (CUSL)
Author:
Ethics Committee
Target Audience:
Researchers, Clinical Trial Investigators
Period of Validity:
2021-2022
Approval Date:
N/A
Date of Changes:
N/A
Year:
2019
Region / City:
Toronto, Canada
Topic:
Informed consent, Clinical trial
Document Type:
Template, Informed consent form
Institution:
SickKids
Author:
SickKids REB
Target Audience:
Parents, Researchers
Effective Period:
N/A
Approval Date:
November 14, 2019
Modification Date:
N/A
Year:
2019
Region / City:
SickKids, Canada
Topic:
Clinical Trial Consent Form
Document Type:
Template
Organization:
SickKids Research Ethics Board
Author:
SickKids
Target Audience:
Research Teams, Clinical Trial Participants
Effective Period:
N/A
Approval Date:
N/A
Amendment Date:
N/A
Year:
Spring 2009
Region / City:
Dartmouth-Hitchcock Medical Center
Subject:
Interventional Radiology Procedures
Document Type:
Clinical Manual
Institution:
Dartmouth-Hitchcock Medical Center
Author:
Not specified
Target Audience:
Medical professionals in interventional radiology
Effective Period:
Ongoing for clinical rotations
Approval Date:
Spring 2009
Date of Last Revision:
Not specified
Year:
2024
Region / City:
United Kingdom
Topic:
Health Technology Evaluation
Document Type:
Meeting Minutes
Organ / Institution:
National Institute for Health and Care Excellence (NICE)
Author:
Committee members and NICE staff
Target Audience:
Healthcare professionals, policy makers, and stakeholders in health technology evaluation
Period of validity:
10 October 2024
Approval Date:
10 October 2024
Date of Changes:
None
Note:
Year
Topic:
Clinical Research / Protocol Development
Document Type:
Protocol Template
Organization / Institution:
DMID
Author:
DMID
Target Audience:
Clinical Researchers, Investigators
Year:
2023
Region / city:
Livingstone, Zambia; Lusaka, Zambia; Twickenham, London, UK; Nashville, TN, USA
Subject:
Hypertension, dietary salt, inflammation
Document type:
Research study
Organization / institution:
Mulungushi University, University of Zambia, St. Mary’s University, Vanderbilt University Medical Center
Author:
Sepiso K. Masenga, Leta Pilic, Benson M. Hamooya, Selestine Nzala, Geoffrey Kwenda, Douglas C. Heimburger, Wilbroad Mutale, John R. Koethe, Annet Kirabo, Sody M. Munsaka
Target audience:
Researchers, healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Document type:
Sponsor statement template
Subject:
Use of Belgian Model Informed Consent Form for vaccine trials in adult healthy volunteers
Related procedure:
Clinical trial application
Scope:
Interventional trials with investigational vaccines
Geographical reference:
Belgium
Applicable to:
Sponsors of clinical trials
Referenced document:
Belgian Model ICF for Vaccine Trials in Adult Healthy Volunteers
Required information:
EU number, trial number, sponsor details, adaptations to mandatory text if applicable
Signature requirement:
Sponsor representative in the Member State
Date format:
DD/MMM/YYYY
Year:
2019
Location:
Minneapolis, MN, USA
Subject:
Construction and Site Preparation for Interventional Radiology Rooms
Document Type:
Government Solicitation / Contract Offer
Issuing Agency:
Department of Veterans Affairs, Program Contracting Activity Central
Author/Contracting Officer:
Bailey E. Donato
Target Audience:
Service-Disabled Veteran-Owned Small Businesses (SDVOSB)
Contract Value:
Between $2,000,000 and $5,000,000
Performance Period:
To be specified in the contract after award
Submission Deadline:
April 16, 2019, 3:00 PM EST
Contract Method:
Sealed Bid / Negotiated RFP
Legal Reference:
38 U.S.C. § 8127 (Public Law 109-461)
Required Documentation:
Performance and payment bonds if applicable, completed offer forms, acknowledgment of amendments
Year:
2018
Region / City:
Minneapolis, MN
Subject:
Interventional Radiology Physician Services
Document Type:
Contract Award Notice
Agency:
Department of Veterans Affairs
Contracting Office:
NETWORK 23 CONTRACTING OFFICE, 316 Robert Street N., St. Paul, MN 55101
Award Number:
36C26318C0043
Award Amount:
$1,497,228.00
Award Date:
02-05-2018
Awardee Name:
MINNEAPOLIS RADIOLOGY
Awardee DUNS Number:
078882836
Awardee Address:
2955 XENIUM LN N STE 40, MINNEAPOLIS, MN 55441
Point of Contact:
[email protected]
NAICS Code:
621111
Set-Aside:
Not specified
Archive Days:
Not specified
Recovery Act Funds:
Not specified
Protocol version:
6.0
Date:
18 September 2020
Study name:
rEECur
Study design:
International randomised controlled trial
Medical condition:
Recurrent and primary refractory Ewing sarcoma
Intervention:
Chemotherapy
Sponsor:
University of Birmingham
Sponsor protocol number:
RG_13-277
CRCTU number:
SA2015
EudraCT number:
2014-000259-99
ISRCTN reference number:
ISRCTN36453794
Chief Investigator:
Dr Martin McCabe
Coordinating institution:
Cancer Research UK Clinical Trials Unit, University of Birmingham
Geographic scope:
International
Participating regions:
United Kingdom, Germany, Italy, France, Spain, Scandinavia, Australia, New Zealand, Switzerland
Target population:
Patients with recurrent or primary refractory Ewing sarcoma
Regulatory status:
Ethics and regulatory approval required per participating country
Amendment history:
Substantial amendments between 2014 and 2016
Document type:
Clinical trial protocol
Randomisation method:
Centralised online randomisation
Trial phase:
Phase II (Germany-specific limitation noted)
Year:
2024
Region / city:
United Kingdom
Topic:
Health technology assessment
Document type:
Appeal hearing report
Organization:
National Institute for Health and Care Excellence (NICE)
Author:
NICE
Target audience:
Healthcare professionals, industry representatives, public
Period of validity:
Not specified
Approval date:
23 September 2024
Date of changes:
Not specified
Year:
2021
Region / city:
London, UK
Theme:
Refractory Disease, Rheumatoid Arthritis, Juvenile Idiopathic Arthritis
Document type:
Systematic review
Organization / institution:
King’s College London
Authors:
Hema Chaplin, Lewis Carpenter, Anni Raz, Elena Nikiphorou, Heidi Lempp, Sam Norton
Target audience:
Medical professionals, researchers in rheumatology
Period of validity:
Not applicable
Date of approval:
Not stated
Date of amendments:
25.01.2021
Year:
2016
Region / city:
Australia
Topic:
Multiple myeloma treatment
Document type:
Submission for listing consideration
Organ / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Takeda Pharmaceuticals Australia Pty Ltd
Target audience:
PBAC, healthcare professionals
Period of validity:
Ongoing treatment
Approval date:
15 November 2016
Date of changes:
N/A
Year:
2023
Region / City:
UK
Topic:
Medical / Health
Document Type:
Guidance
Institution:
National Institute for Health and Care Excellence (NICE)
Author:
Dr. Mark Chakravarty
Target Audience:
Pharmaceutical companies, healthcare professionals
Validity Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified